Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Becton Dickinson & Co (BDX)
since 2015 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Becton Dickinson & Co.
Table 2 shows the detailed insider transactions.
This company's CIK number is 10795.
Total stock buying since 2015: $1,551,278.
Total stock sales since 2015: $276,123,430.
Total stock option exercises since 2015: $176,912,175.
Table 3. Detailed insider trading at Becton Dickinson & Co (BDX)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2025-08-22 | Feld Michael (EVP & President, Life Sciences) | Sale | 57 | 197.99 | 11,285 |
| 2025-08-11 | Hayes Gregory (Director) | Buy | 5,250 | 191.57 | 1,005,742 |
| 2025-08-08 | Fraser Claire (Director) | Sale | 863 | 192.30 | 165,954 |
| 2025-07-18 | Garrison Michael David (EVP & President, Medical) | Sale | 1,185 | 180.90 | 214,360 |
| 2025-07-18 | Garrison Michael David (EVP & President, Medical) | Option Ex | 6,360 | 147.68 | 939,244 |
| 2025-06-02 | Shan David (EVP and Chief ISC Officer) | Sale | 1,166 | 171.19 | 199,607 |
| 2025-04-09 | Garrison Michael David (EVP & President, Medical) | Sale | 479 | 197.28 | 94,497 |
| 2025-03-18 | Byrd Richard (EVP & President Interventional) | Sale | 459 | 230.00 | 105,570 |
| 2025-03-12 | Byrd Richard (EVP & President Interventional) | Sale | 1,940 | 224.91 | 436,325 |
| 2025-02-10 | Henderson Jeffrey William (Director) | Buy | 1,500 | 233.62 | 350,430 |
| 2025-01-21 | Shan David (EVP and Chief ISC Officer) | Sale | 500 | 240.00 | 120,000 |
| 2025-01-21 | Neal Shana Carol (EVP and Chief People Officer) | Sale | 787 | 240.00 | 188,880 |
| 2025-01-17 | Garrison Michael David (EVP & President, Medical) | Sale | 597 | 236.51 | 141,196 |
| 2025-01-07 | Neal Shana Carol (EVP and Chief People Officer) | Sale | 788 | 235.00 | 185,180 |
| 2024-12-19 | Garrison Michael David (EVP & President, Medical) | Sale | 2,838 | 223.33 | 633,810 |
| 2024-12-09 | Goette Roland (EVP and President, EMEA) | Sale | 638 | 219.03 | 139,741 |
| 2024-12-06 | Neal Shana Carol (EVP and Chief People Officer) | Sale | 1,000 | 220.49 | 220,490 |
| 2024-12-06 | Goette Roland (EVP and President, EMEA) | Sale | 4,483 | 221.01 | 990,787 |
| 2024-12-06 | Goette Roland (EVP and President, EMEA) | Option Ex | 13,334 | 157.79 | 2,104,038 |
| 2024-12-05 | Shan David (EVP and Chief ISC Officer) | Sale | 1,500 | 220.25 | 330,375 |
| 2024-11-21 | Neal Shana Carol (EVP and Chief People Officer) | Option Ex | 111 | .00 | 0 |
| 2024-08-14 | Goette Roland (EVP and President EMEA) | Option Ex | 5,295 | 132.54 | 701,799 |
| 2024-06-10 | Spoerel Thomas J (SVP,Controller&Chief Acct Officer) | Sale | 300 | 239.31 | 71,793 |
| 2024-05-15 | Goette Roland (EVP and President EMEA) | Sale | 3,300 | 236.58 | 780,714 |
| 2024-05-13 | Goette Roland (EVP and President EMEA) | Sale | 3,300 | 237.11 | 782,453 |
| 2024-04-30 | Garrison Michael David (EVP & President Medical) | Sale | 1,715 | 232.81 | 399,269 |
| 2024-03-14 | Spoerel Thomas J (SVP,Controller&Chief Acct Officer) | Sale | 282 | 238.29 | 67,197 |
| 2023-12-11 | Garrison Michael David (EVP & President Medical) | Sale | 1,239 | 232.46 | 288,017 |
| 2023-11-28 | Byrd Richard (EVP & President Interventional) | Sale | 2,156 | 238.47 | 514,141 |
| 2023-11-20 | Neal Shana Carol (EVP and Chief People Officer) | Option Ex | 110 | .00 | 0 |
| 2023-11-16 | Goette Roland (EVP and President, EMEA) | Option Ex | 3,544 | 107.12 | 379,633 |
| 2023-09-05 | Byrd Richard (EVP & President Interventional) | Sale | 459 | 274.48 | 125,986 |
| 2023-08-28 | Fraser Claire (Director) | Sale | 848 | 281.66 | 238,847 |
| 2023-08-11 | Hickey David (EVP & President, Life Sciences) | Sale | 2,974 | 277.85 | 826,325 |
| 2023-08-11 | Hickey David (EVP & President, Life Sciences) | Option Ex | 3,883 | 132.54 | 514,652 |
| 2023-08-08 | Garrison Michael David (EVP & President Medical) | Sale | 1,300 | 277.13 | 360,269 |
| 2023-02-03 | Byrd Richard (EVP & President Interventional) | Sale | 1,421 | 248.60 | 353,260 |
| 2022-11-18 | Neal Shana Carol (EVP and Chief People Officer) | Option Ex | 110 | .00 | 0 |
| 2022-11-16 | Goette Roland (EVP and President, EMEA) | Option Ex | 4,617 | 74.94 | 345,997 |
| 2022-08-15 | Hickey David (EVP & President, Life Sciences) | Sale | 475 | 265.00 | 125,875 |
| 2022-08-15 | Polen Thomas E Jr (Chairman, CEO and President) | Sale | 9,500 | 265.13 | 2,518,735 |
| 2022-08-15 | Polen Thomas E Jr (Chairman, CEO and President) | Option Ex | 15,000 | 167.91 | 2,518,650 |
| 2022-08-09 | Polen Thomas E Jr (Executive Vice President) | Sale | 1,652 | 260.00 | 429,520 |
| 2022-08-09 | Polen Thomas E Jr (Executive Vice President) | Option Ex | 3,825 | 147.68 | 564,876 |
| 2022-08-09 | Khichi Samrat S. (EVP and General Counsel) | Sale | 9,185 | 260.44 | 2,392,141 |
| 2022-08-09 | Khichi Samrat S. (EVP and General Counsel) | Option Ex | 26,815 | 100.87 | 2,704,829 |
| 2022-08-08 | Khichi Samrat S. (EVP and General Counsel) | Sale | 7,295 | 260.44 | 1,899,909 |
| 2022-06-07 | Spoerel Thomas J (VP Controller & Chief Acct Officer) | Sale | 443 | 260.00 | 115,180 |
| 2022-06-07 | Spoerel Thomas J (VP Controller & Chief Acct Officer) | Option Ex | 1,026 | 147.68 | 151,519 |
| 2022-05-06 | Hickey David (EVP & President, Life Sciences) | Sale | 475 | 256.00 | 121,600 |
| 2022-02-25 | Larson Betty D (EVP HR & CHRO) | Sale | 14,374 | 271.90 | 3,908,290 |
| 2022-02-25 | Larson Betty D (EVP HR & CHRO) | Option Ex | 46,658 | 193.09 | 9,009,099 |
| 2022-02-08 | Fraser Claire (Director) | Sale | 841 | 271.70 | 228,499 |
| 2022-02-03 | Conroy Alexandre (EVP of Integrated Supply Chain) | Sale | 6,410 | 270.16 | 1,731,725 |
| 2022-02-03 | Conroy Alexandre (EVP of Integrated Supply Chain) | Option Ex | 12,787 | 134.73 | 1,722,792 |
| 2021-12-16 | Larson Betty D (EVP HR & CHRO) | Sale | 3,341 | 255.00 | 851,955 |
| 2021-12-16 | Larson Betty D (EVP HR & CHRO) | Option Ex | 893 | 97.14 | 86,746 |
| 2021-12-07 | Spoerel Thomas J (VP Controller & Chief Acct Officer) | Sale | 233 | 250.00 | 58,250 |
| 2021-11-16 | Goette Roland (EVP and President, EMEA) | Option Ex | 3,055 | 72.12 | 220,326 |
| 2021-09-08 | Hickey David (EVP & President, Life Sciences) | Sale | 500 | 260.00 | 130,000 |
| 2021-09-08 | Spoerel Thomas J (VP Controller & Chief Acct Officer) | Sale | 267 | 260.00 | 69,420 |
| 2021-09-08 | Rimel Rebecca W | Sale | 500 | 260.00 | 130,000 |
| 2021-09-03 | Lim James C (Executive Vice President) | Sale | 6,956 | 257.44 | 1,790,752 |
| 2021-09-03 | Lim James C (Executive Vice President) | Option Ex | 14,584 | 134.73 | 1,964,902 |
| 2021-09-03 | Rimel Rebecca W | Sale | 500 | 257.10 | 128,550 |
| 2021-09-02 | Rimel Rebecca W | Sale | 244 | 254.00 | 61,976 |
| 2021-08-30 | Rimel Rebecca W | Sale | 207 | 252.00 | 52,164 |
| 2021-08-18 | Fraser Claire | Sale | 387 | 251.58 | 97,361 |
| 2021-08-17 | Rimel Rebecca W | Sale | 207 | 252.00 | 52,164 |
| 2021-08-06 | Spoerel Thomas J (VP Controller & Chief Acct Officer) | Sale | 266 | 242.30 | 64,451 |
| 2021-05-28 | Lim James C (Executive Vice President) | Sale | 3,429 | 241.68 | 828,720 |
| 2021-05-27 | Fraser Claire | Sale | 390 | 241.36 | 94,130 |
| 2020-11-23 | Goette Roland (EVP and President, EMEA) | Sale | 930 | 230.10 | 213,993 |
| 2020-11-23 | Goette Roland (EVP and President, EMEA) | Option Ex | 3,485 | 76.64 | 267,090 |
| 2020-07-09 | Kaltenbach Patrick (EVP & Pres Life Sciences) | Sale | 1,272 | 260.00 | 330,720 |
| 2020-06-05 | Kaltenbach Patrick (EVP & Pres Life Sciences) | Sale | 1,049 | 243.20 | 255,116 |
| 2020-06-02 | Kaltenbach Patrick (EVP & Pres Life Sciences) | Sale | 222 | 244.83 | 54,352 |
| 2020-05-08 | Fraser Claire (Director) | Sale | 771 | 256.56 | 197,807 |
| 2020-03-16 | Khichi Samrat S. (EVP and General Counsel) | Sale | 4,349 | 224.53 | 976,480 |
| 2020-02-11 | Fraser Claire (Director) | Sale | 1,500 | 258.71 | 388,072 |
| 2020-02-04 | Campion Simon D (EVP and Segment President) | Sale | 8,085 | 285.09 | 2,304,952 |
| 2020-02-04 | Campion Simon D (EVP and Segment President) | Option Ex | 13,612 | 105.43 | 1,435,058 |
| 2020-02-04 | Mas Ribo Alberto (EVP and Pres, Life Sciences) | Sale | 1,430 | 285.00 | 407,550 |
| 2020-01-28 | Forlenza Vincent A (Chairman, CEO and President) | Sale | 28,514 | 280.96 | 8,011,293 |
| 2020-01-28 | Forlenza Vincent A (Chairman, CEO and President) | Option Ex | 38,362 | 72.12 | 2,766,667 |
| 2020-01-27 | Forlenza Vincent A (Chairman, CEO and President) | Sale | 25,546 | 280.09 | 7,155,179 |
| 2020-01-27 | Forlenza Vincent A (Chairman, CEO and President) | Option Ex | 34,406 | 72.12 | 2,481,360 |
| 2020-01-24 | Forlenza Vincent A (Chairman, CEO and President) | Sale | 7,177 | 280.13 | 2,010,493 |
| 2020-01-24 | Forlenza Vincent A (Chairman, CEO and President) | Option Ex | 9,666 | 72.12 | 697,111 |
| 2020-01-23 | Forlenza Vincent A (Chairman, CEO and President) | Sale | 6,284 | 280.06 | 1,759,897 |
| 2020-01-23 | Forlenza Vincent A (Chairman, CEO and President) | Option Ex | 8,464 | 72.12 | 610,423 |
| 2020-01-10 | Forlenza Vincent A (Chairman, CEO and President) | Sale | 19,675 | 275.15 | 5,413,576 |
| 2020-01-10 | Forlenza Vincent A (Chairman, CEO and President) | Option Ex | 26,665 | 72.12 | 1,923,079 |
| 2020-01-08 | Forlenza Vincent A (Chairman, CEO and President) | Sale | 13,860 | 275.19 | 3,814,133 |
| 2020-01-08 | Forlenza Vincent A (Chairman, CEO and President) | Option Ex | 18,783 | 72.12 | 1,354,629 |
| 2020-01-02 | Forlenza Vincent A (Chairman, CEO and President) | Sale | 33,365 | 271.28 | 9,051,257 |
| 2020-01-02 | Forlenza Vincent A (Chairman, CEO and President) | Option Ex | 45,448 | 72.12 | 3,277,709 |
| 2019-12-16 | Mas Ribo Alberto (EVP and Pres, Life Sciences) | Sale | 11,860 | 269.51 | 3,196,388 |
| 2019-12-16 | Mas Ribo Alberto (EVP and Pres, Life Sciences) | Option Ex | 12,153 | 134.73 | 1,637,373 |
| 2019-12-16 | Polen Thomas E Jr (Executive Vice President) | Sale | 6,386 | 269.63 | 1,721,857 |
| 2019-12-16 | Polen Thomas E Jr (Executive Vice President) | Option Ex | 13,907 | 142.43 | 1,980,704 |
| 2019-12-13 | Spoerel Thomas J (VP Controller & Chief Acct Officer) | Sale | 506 | 267.95 | 135,582 |
| 2019-12-12 | Kaltenbach Patrick (EVP & Pres Life Sciences) | Sale | 339 | 263.23 | 89,234 |
| 2019-12-12 | Kaltenbach Patrick (EVP & Pres Life Sciences) | Option Ex | 4,236 | 242.10 | 1,025,535 |
| 2019-12-12 | Forlenza Vincent A (Chairman, CEO and President) | Sale | 11,626 | 265.57 | 3,087,516 |
| 2019-12-12 | Forlenza Vincent A (Chairman, CEO and President) | Option Ex | 16,343 | 76.64 | 1,252,527 |
| 2019-12-06 | Kaltenbach Patrick (EVP & Pres Life Sciences) | Sale | 312 | 261.51 | 81,591 |
| 2019-09-06 | Bodner Charles R (SVP Corp Fin Chief Acct Office) | Sale | 1,514 | 260.08 | 393,761 |
| 2019-09-06 | Bodner Charles R (SVP Corp Fin Chief Acct Office) | Option Ex | 3,143 | 134.73 | 423,456 |
| 2019-09-06 | Polen Thomas E Jr (Executive Vice President) | Sale | 5,823 | 260.26 | 1,515,493 |
| 2019-09-06 | Polen Thomas E Jr (Executive Vice President) | Option Ex | 13,760 | 150.12 | 2,065,651 |
| 2019-09-06 | Lim James C (Executive Vice President) | Sale | 9,299 | 263.53 | 2,450,565 |
| 2019-09-06 | Lim James C (Executive Vice President) | Option Ex | 15,848 | 108.89 | 1,725,688 |
| 2019-09-06 | Forlenza Vincent A (Chairman, CEO and President) | Sale | 11,532 | 260.38 | 3,002,702 |
| 2019-09-06 | Forlenza Vincent A (Chairman, CEO and President) | Option Ex | 16,343 | 76.64 | 1,252,527 |
| 2019-08-30 | Conroy Alexandre (EVP of Integrated Supply Chain) | Sale | 46 | 256.72 | 11,809 |
| 2019-08-29 | Conroy Alexandre (EVP of Integrated Supply Chain) | Sale | 9,829 | 255.06 | 2,506,984 |
| 2019-08-09 | Kaltenbach Patrick (EVP & Pres Life Sciences) | Sale | 127 | 253.78 | 32,230 |
| 2019-08-09 | Lim James C (Executive Vice President) | Sale | 23,879 | 253.31 | 6,048,789 |
| 2019-08-09 | Lim James C (Executive Vice President) | Option Ex | 33,966 | 74.98 | 2,546,770 |
| 2019-08-08 | Goette Roland (EVP and President, EMEA) | Sale | 1,717 | 249.88 | 429,043 |
| 2019-08-08 | Goette Roland (EVP and President, EMEA) | Option Ex | 2,463 | 75.63 | 186,276 |
| 2019-08-08 | Kaltenbach Patrick (EVP & Pres Life Sciences) | Sale | 400 | 246.54 | 98,618 |
| 2019-08-08 | Kaltenbach Patrick (EVP & Pres Life Sciences) | Option Ex | 2,865 | 224.94 | 644,453 |
| 2019-08-08 | Lim James C (Executive Vice President) | Sale | 1,929 | 252.01 | 486,127 |
| 2019-08-08 | Lim James C (Executive Vice President) | Option Ex | 2,773 | 76.64 | 212,522 |
| 2019-08-07 | Fraser Claire (Director) | Sale | 1,429 | 243.26 | 347,618 |
| 2019-06-12 | Campion Simon D (EVP and Segment President) | Sale | 2,903 | 236.94 | 687,836 |
| 2019-06-10 | Kaltenbach Patrick (EVP & Pres Life Sciences) | Sale | 191 | 241.03 | 46,036 |
| 2019-06-10 | Kaltenbach Patrick (EVP & Pres Life Sciences) | Option Ex | 2,865 | 224.94 | 644,453 |
| 2019-06-04 | Kaltenbach Patrick (EVP & Pres Life Sciences) | Sale | 275 | 235.00 | 64,625 |
| 2019-05-21 | Khichi Samrat S. (EVP and General Counsel) | Sale | 16,085 | 234.68 | 3,774,827 |
| 2019-05-13 | Larson Betty D (EVP HR & CHRO) | Sale | 1,700 | 224.95 | 382,415 |
| 2019-05-13 | Larson Betty D (EVP HR & CHRO) | Option Ex | 2,200 | 97.14 | 213,708 |
| 2019-04-17 | Burzik Catherine M (Director) | Sale | 45 | 223.04 | 10,036 |
| 2019-04-16 | Burzik Catherine M (Director) | Buy | 30 | 247.96 | 7,438 |
| 2019-03-15 | Mas Ribo Alberto (EVP and Pres, Life Sciences) | Sale | 2,104 | 255.00 | 536,520 |
| 2019-03-15 | Mas Ribo Alberto (EVP and Pres, Life Sciences) | Option Ex | 3,483 | 108.89 | 379,263 |
| 2019-03-15 | Forlenza Vincent A (Chairman, CEO and President) | Sale | 8,309 | 255.13 | 2,119,875 |
| 2019-03-15 | Forlenza Vincent A (Chairman, CEO and President) | Option Ex | 11,878 | 76.64 | 910,329 |
| 2019-03-04 | Mas Ribo Alberto (EVP and Pres, Life Sciences) | Sale | 4,808 | 255.03 | 1,226,184 |
| 2019-03-04 | Mas Ribo Alberto (EVP and Pres, Life Sciences) | Option Ex | 4,864 | 108.89 | 529,640 |
| 2019-03-04 | Forlenza Vincent A (Chairman, CEO and President) | Sale | 3,123 | 255.03 | 796,458 |
| 2019-03-04 | Forlenza Vincent A (Chairman, CEO and President) | Option Ex | 4,465 | 76.64 | 342,197 |
| 2019-02-25 | Forlenza Vincent A (Chairman, CEO and President) | Sale | 11,340 | 250.40 | 2,839,536 |
| 2019-02-25 | Forlenza Vincent A (Chairman, CEO and President) | Option Ex | 16,343 | 76.64 | 1,252,527 |
| 2018-11-30 | Borzi James W (EVP & Chief Supply Chain Offcr) | Sale | 5,887 | 252.37 | 1,485,719 |
| 2018-11-30 | Borzi James W (EVP & Chief Supply Chain Offcr) | Option Ex | 10,405 | 151.85 | 1,579,968 |
| 2018-11-16 | Bodner Charles R (SVP Corp Fin Chief Acct Office) | Sale | 2,080 | 245.83 | 511,326 |
| 2018-11-16 | Bodner Charles R (SVP Corp Fin Chief Acct Office) | Option Ex | 2,500 | 134.73 | 336,825 |
Insider trading activities including stock purchases, stock sales, and option exercises
of BDX listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Becton Dickinson & Co (symbol BDX,
CIK number 10795) see
the Securities and Exchange Commission (SEC) website.